> Concomitant administration of patiromer did  not affect the bioavailability as measured by the area under the curve (AUC) of AMLODIPINE , CINACALCET, CLOPIDOGREL, FUROSEMIDE, LITHIUM, METOPROLOL, TRIMETHOPRIM, VERAPAMIL and WARFARIN. For these medicinal products no separation is needed.  Concomitant administration of patiromer showed reduced bioavailability of CIPROFLOXACIN, LEVOTHYROXINE and METFORMIN. However, there was no interaction when patiromer and these medicinal products were taken 3  hours apart. 
